Fresenius Dialysis Solution Litigation Settles For $250M, Company Announces

(February 18, 2016, 11:26 AM EST) -- BAD HOMBURG, Germany — Fresenius Medical Care AG & Co. KGaA on Feb. 17 said in a press release that it has reached an agreement in principle to resolve U.S. litigation involving its GranuFlo and NaturaLyte dialysis solutions for $250 million.

The parent company said its Fresenius Medical Care North America subsidiary reached the agreement with a plaintiffs’ committee It said the agreement is contingent on 97 percent of the plaintiffs agreeing to participate in the settlement by July.

The company said $220 million will come...
To view the full article, register now.